Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical Trial.
Moore CM, Robertson NL, Jichi F, Damola A, Ambler G, Giganti F, Ridout AJ, Bott SR, Winkler M, Ahmed HU, Arya M, Mitra AV, McCartan N, Freeman A, Jameson C, Castro R, Gambarota G, Whitcher BJ, Allen C, Kirkham A, Emberton M. Moore CM, et al. Among authors: gambarota g. J Urol. 2017 Apr;197(4):1006-1013. doi: 10.1016/j.juro.2016.11.090. Epub 2016 Nov 19. J Urol. 2017. PMID: 27871928 Free article. Clinical Trial.
MAPPED study design: a 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging.
Robertson NL, Moore CM, Ambler G, Bott SR, Freeman A, Gambarota G, Jameson C, Mitra AV, Whitcher B, Winkler M, Kirkham A, Allen C, Emberton M. Robertson NL, et al. Among authors: gambarota g. Contemp Clin Trials. 2013 Jan;34(1):80-9. doi: 10.1016/j.cct.2012.10.003. Epub 2012 Oct 17. Contemp Clin Trials. 2013. PMID: 23085153 Clinical Trial.
Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.
Giganti F, Gambarota G, Moore CM, Robertson NL, McCartan N, Jameson C, Bott SRJ, Winkler M, Whitcher B, Castro-Santamaria R, Emberton M, Allen C, Kirkham A. Giganti F, et al. Among authors: gambarota g. J Magn Reson Imaging. 2018 Jun;47(6):1646-1653. doi: 10.1002/jmri.25891. Epub 2017 Nov 14. J Magn Reson Imaging. 2018. PMID: 29135073 Free article. Clinical Trial.
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial.
Giganti F, Moore CM, Robertson NL, McCartan N, Jameson C, Bott SRJ, Winkler M, Gambarota G, Whitcher B, Castro R, Emberton M, Allen C, Kirkham A. Giganti F, et al. Among authors: gambarota g. Eur Radiol. 2017 Nov;27(11):4767-4774. doi: 10.1007/s00330-017-4858-0. Epub 2017 May 18. Eur Radiol. 2017. PMID: 28523355 Free PMC article. Clinical Trial.
A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers.
Libri V, Brown AP, Gambarota G, Haddad J, Shields GS, Dawes H, Pinato DJ, Hoffman E, Elliot PJ, Vlasuk GP, Jacobson E, Wilkins MR, Matthews PM. Libri V, et al. Among authors: gambarota g. PLoS One. 2012;7(12):e51395. doi: 10.1371/journal.pone.0051395. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284689 Free PMC article. Clinical Trial.
Fluid and white matter suppression with the MP2RAGE sequence.
Tanner M, Gambarota G, Kober T, Krueger G, Erritzoe D, Marques JP, Newbould R. Tanner M, et al. Among authors: gambarota g. J Magn Reson Imaging. 2012 May;35(5):1063-70. doi: 10.1002/jmri.23532. Epub 2011 Dec 14. J Magn Reson Imaging. 2012. PMID: 22170818
Pragmatic study of orlistat 60 mg on abdominal obesity.
Thomas EL, Makwana A, Newbould R, Rao AW, Gambarota G, Frost G, Delafont B, Mishra RG, Matthews PM, Berk ES, Schwartz SM, Bell JD, Beaver JD. Thomas EL, et al. Among authors: gambarota g. Eur J Clin Nutr. 2011 Nov;65(11):1256-62. doi: 10.1038/ejcn.2011.108. Epub 2011 Jun 22. Eur J Clin Nutr. 2011. PMID: 21697820 Clinical Trial.
Comparison of 18F-Choline PET/CT and MRI functional parameters in prostate cancer.
Palard-Novello X, Beuzit L, Gambarota G, Le Jeune F, Garin E, Salaün PY, Devillers A, Querellou S, Bourguet P, Saint-Jalmes H. Palard-Novello X, et al. Among authors: gambarota g. Ann Nucl Med. 2019 Jan;33(1):47-54. doi: 10.1007/s12149-018-1302-8. Epub 2018 Sep 15. Ann Nucl Med. 2019. PMID: 30219990
82 results